Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,639 | -92,458 | -39,990 | -14,214 | -1,280 |
| Depreciation Amortization | 4,071 | 2,575 | 896 | 265 | 18 |
| Accounts payable and accrued liabilities | 95 | 2,856 | 164 | 520 | 273 |
| Other Working Capital | 711 | 7,082 | 3,436 | 351 | 242 |
| Other Operating Activity | 8,652 | 29,145 | 3,006 | 3 | -244 |
| Operating Cash Flow | $-90,110 | $-50,800 | $-32,488 | $-13,075 | $-991 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,376 | -3,522 | -3,101 | -678 | -306 |
| Purchase Of Investment | -123,857 | -148,111 | -89,286 | N/A | N/A |
| Sale Of Investment | 140,501 | 90,662 | 18,058 | 0 | N/A |
| Investing Cash Flow | $14,268 | $-60,971 | $-74,329 | $-678 | $-306 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 17,116 | 10,000 | 21,000 | 11,000 | 500 |
| Debt Repayment | -17,438 | N/A | -11,050 | -1,500 | N/A |
| Common Stock Issued | 54,302 | 141,980 | 51,589 | 51,017 | N/A |
| Other Financing Activity | -181 | -172 | -180 | 8 | 5,673 |
| Financing Cash Flow | $53,799 | $151,808 | $61,359 | $60,525 | $6,173 |
| Beginning Cash Position | 46,383 | 6,346 | 51,804 | 5,032 | 156 |
| End Cash Position | 24,340 | 46,383 | 6,346 | 51,804 | 5,032 |
| Net Cash Flow | $-22,043 | $40,037 | $-45,458 | $46,772 | $4,876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,110 | -50,800 | -32,488 | -13,075 | -991 |
| Capital Expenditure | -2,451 | -3,522 | -3,117 | -688 | -306 |
| Free Cash Flow | -92,561 | -54,322 | -35,605 | -13,763 | -1,297 |